Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing efimosfermin alfa, an investigational, once-monthly FGF21 analogue for the treatment of metabolic dysfunction-associated ...

• There is not enough evidence to determine the best method for preventing haemolytic uraemic syndrome (HUS) in patients with Shiga toxin-producing Escherichia coli (STEC)-associated diarrhoea. • More ...

Around the town of Kazanlak in central Bulgaria, a "vast plain" unfurls between two mountain ranges. It is known as the Rose ...

This was a low-key week for the biotech sector before the onset of the first-quarter earnings season. Biotech giant Bristol Myers Squibb BMY was down on data from the schizophrenia study while ...

Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...

Forty-five years of retrospect on the Grateful Dead's eleventh studio record, Go to Heaven (released 4/28/80) suggests the ...

Robert F. Kennedy, Jr., declared chronic diseases an “existential threat.” Then his agency terminated one of the world’s ...

As therapy becomes more common, concerns grow over medication dependency, the effectiveness of young therapists, and whether modern mental health treatment is addressing deeper societal issues.

Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the ...

This caught me by immediate surprise. To my dismay, her friend agreed. I was dumbfounded and confused how anybody at this age ...

A novel AI tool called MindGlide extracts key biomarkers from MRI scans to help interpret and assess treatment efficacy in ...

The University of Cambridge–based DioSynVax and Singapore's ACM Biolabs have signed a deal to jointly develop a ...